reports
1 director sold
A director at Ascendis Health Ltd sold 2,634,840 shares at 3.917ZAR and the significance rating of the trade was 98/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years c...
- Tumi Makoah
Ascendis Health (ASC ) - Under Pressure
Summary Ascendis second rights issue in as many years is meant to manage the c. ZAR2bn worth of deferred vendor liabilities as a result of acquisitions. The subscription price of ZAR20 is at a premium to the 30-day VWAP and lower than the ZAR22 price of the first rights issue. We also show that ASC share price has always traded at a premium to NAV and that on 30 June 2017, it was trading at c.76% premium to NAV. On a divisional basis, organic sales growth for the Consumer Brands division has ...
Ford Equity International Rating and Forecast Report
Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.